Samarth Kulkarni, Chief Executive Officer at CRISPR Therapeutics AG, sold CRSP on Oct 14, 2026
Data as of Oct 16
▼ SELL$202K4,098 shares at $49.26Samarth Kulkarni Chief Executive OfficerCRSP CRISPR Therapeutics AG
- Traded
- Oct 14, 2026
- Disclosed
- Oct 15, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CRSP since disclosure
−4.4%
after the sale
Similar stocks (XLV) since disclosure
−0.3%
XLV — its sector index fund
Change in closing price from Oct 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.